Autoantigen-specific TGFβ-induced Foxp3+ regulatory T cells prevent autoimmunity by inhibiting dendritic cells from activating autoreactive T cells

Journal of Immunology

Volumn 179, Issue 7, 2007, Pages 4685-4693

  DiPaolo, Richard J ^a   Brinster, Carine ^a   Davidson, Todd S ^a   Andersson, John ^a   Glass, Deborah ^a   Shevach, Ethan M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; HYDROGEN POTASSIUM ADENOSINE TRIPHOSPHATASE; ICOS LIGAND; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROGRAMMED DEATH LIGAND 1; PROGRAMMED DEATH LIGAND 2; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; AUTOANTIGEN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; EXPERIMENTAL MODEL; FEMALE; GASTRITIS; HISTOPATHOLOGY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ANIMAL; ANTIBODY SPECIFICITY; CD4 LYMPHOCYTE COUNT; CELL CULTURE; CYTOLOGY; DRUG EFFECT; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPH NODE; LYMPHOCYTE ACTIVATION; METABOLISM; PHENOTYPE; TIME;

ANIMALS; ANTIGENS, CD80; ANTIGENS, CD86; AUTOANTIGENS; AUTOIMMUNITY; CD4 LYMPHOCYTE COUNT; CELLS, CULTURED; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 1; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GASTRITIS; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; ORGAN SPECIFICITY; PHENOTYPE; T-LYMPHOCYTES, REGULATORY; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 44649144463     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.7.4685     Document Type: Article

References (44)

1. + regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6: 345-352.
2. Chatenoud, L., B. Salomon, and J. A. Bluestone. 2001. Suppressor T cells: they're back and critical for regulation of autoimmunity! Immunol. Rev. 182: 149-163.
3. + suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2: 389-400.
4. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188: 287-296.
5. von Boehmer, H. 2005. Mechanisms of suppression by suppressor T cells. Nat. Immunol. 6: 338-344.
6. Kanagawa, O., A. Militech, and B. A. Vaupel. 2002. Regulation of diabetes development by regulatory T cells in pancreatic islet antigen-specific TCR transgenic nonobese diabetic mice. J. Immunol. 168: 6159-6164.
7. + regulatory T cells from nonobese diabetic mice. J. Immunol. 175: 3053-3059.
8. Tang, Q., K. J. Henriksen, M. Bi, E. B. Finger, G. Szot, J. Ye, E. L. Masteller, H. McDevitt, M. Bonyhadi, and J. A. Bluestone. 2004. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 199: 1455-1465.
9. + T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J. Exp. Med. 199: 1467-1477.
10. + regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice. Proc. Nat. Acad. Sci. USA 99: 8213-8218.
11. Fukuma, K., S. Sakaguchi, K. Kuribayashi, W. L. Chen, R. Morishita, K. Sekita, H. Uchino, and T. Masuda. 1988. Immunologic and clinical studies on murine experimental autoimmune gastritis induced by neonatal thymectomy. Gastroenterology 94: 274-283.
12. + T cells, are required for the development of experimental autoimmune gastritis. Immunology 93: 405-408.
13. Sakaguchi, S., N. Sakaguchi, M. Asano, M. Itoh, and M. Toda. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155: 1151-1164.
14. Scarff, K. J., J. M. Pettitt, I. R. Van Driel, P. A. Gleeson, and B. H. Toh. 1997. Immunization with gastric H+/K(+)-ATPase induces a reversible autoimmune gastritis. Immunology 92: 91-98.
15. Suri-Payer, E., A. Z. Amar, R. McHugh, K. Natarajan, D. H. Margulies, and E. M. Shevach. 1999. Post-thymectomy autoimmune gastritis: fine specificity and pathogenicity of anti-H/K ATPase-reactive T cells. Eur. J. Immunol. 29: 669-677.
16. Candon, S., R. S. McHugh, G. Foucras, K. Natarajan, E. M. Shevach, and D. H. Margulies. 2004. Spontaneous organ-specific Th2-mediated autoimmunity in TCR transgenic mice. J. Immunol. 172: 2917-2924.
17. McHugh, R. S., E. M. Shevach, D. H. Margulies, and K. Natarajan. 2001. A T cell receptor transgenic model of severe, spontaneous organ-specific autoimmunity. Eur. J. Immunol. 31: 2094-2103.
18. Allen, S., S. Read, R. DiPaolo, R. S. McHugh, E. M. Shevach, P. A. Gleeson, and I. R. van Driel. 2005. Promiscuous thymic expression of an autoantigen gene does not result in negative selection of pathogenic T cells. J. Immunol. 175: 5759-5764.
19. Scheinecker, C., R. McHugh, E. M. Shevach, and R. N. Germain. 2002. Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node. J. Exp. Med. 196: 1079-1090.
20. + T cells prevent the development of organ-specific autoimmune disease by inhibiting the differentiation of autoreactive effector T cells. J. Immunol. 175: 7135-7142.
21. - T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 172: 5149-5153.
22. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198: 1875-1886.
23. Weber, S. E., J. Harbertson, E. Godebu, G. A. Mros, R. C. Padrick, B. D. Carson, S. F. Ziegler, and L. M. Bradley. 2006. Adaptive islet-specific regulatory CD4 T cells control autoimmune diabetes and mediate the disappearance of pathogenic Th1 cells in vivo. J. Immunol. 176: 4730-4739.
24. + regulatory T cells generated ex vivo with IL-2 and TGF-β suppress a stimulatory graft-versus-host disease with a lupus-like syndrome. J. Immunol. 172: 1531-1539.
25. + regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease. J. Immunol. 168: 5979-5983.
26. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner, and V. K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
27. + T cells selectively kill B lymphocytes. Blood 107: 3925-3932.
28. Grossman, W. J., J. W. Verbsky, W. Barchet, M. Colonna, J. P. Atkinson, and T. J. Ley. 2004. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 21: 589-601.
29. + regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J. Immunol. 174: 1783-1786.
30. Tang, Q., J. Y. Adams, A. J. Tooley, M. Bi, B. T. Fife, P. Serra, P. Santamaria, R. M. Locksley, M. F. Krummel, and J. A. Bluestone. 2006. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat. Immunol. 7: 83-92.
31. + T cells and dendritic cells in vivo (see comment). J. Exp. Med. 203: 505-511.
32. + regulatory T cells including suppressors of alloreactivity. Immunol. Rev. 212: 314-329.
33. Kryczek, I., S. Wei, L. Zou, G. Zhu, P. Mottram, H. Xu, L. Chen, and W. Zou. 2006. Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells. J. Immunol. 177: 40-44.
34. + T cells. J. Immunol. 176: 6202-6210.
35. + T cells restrain the maturation and antigen-presenting function of dendritic cells. J. Immunol. 172: 4676-4680.
36. + regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur. J. Immunol. 30: 1538-1543.
37. + T cells without reversing their suppressive function. J. Immunol. 175: 7332-7340.
38. + regulatory T cells control T helper cell type 1 responses to foreign antigens induced by mature dendritic cells in vivo. J. Exp. Med. 198: 259-266.
39. + regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 169: 4712-4716.
40. + cells controlling a pathogenic CD4 response inhibit cytokine differentiation, CXCR-3 expression, and tissue invasion. J. Immunol. 173: 2942-2951.
41. + T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion. J. Exp. Med. 199: 1479-1489.
42. Klein, L., K. Khazaie, and H. von Boehmer. 2003. In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc. Natl. Acad. Sci. USA 100: 8886-8891.
43. + regulatory T cells in the regional lymph node. J. Exp. Med. 202: 771-781.
44. Jaeckel, E., H. von Boehmer, and M. P. Manns. 2005. Antigen-specific FoxP3-transduced T-cells can control established type 1 diabetes. Diabetes 54: 306-310.